These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1187 related articles for article (PubMed ID: 33712679)

  • 1. Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population.
    Pallett SJC; Denny SJ; Patel A; Charani E; Mughal N; Stebbing J; Davies GW; Moore LSP
    Sci Rep; 2021 Mar; 11(1):5860. PubMed ID: 33712679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
    Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F
    J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care.
    Ko JH; Joo EJ; Kim SH; Kim YJ; Huh K; Cho SY; Kang CI; Chung DR; Kang ES; Peck KR
    J Microbiol Immunol Infect; 2021 Feb; 54(1):97-100. PubMed ID: 32684340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
    Infantino M; Grossi V; Lari B; Bambi R; Perri A; Manneschi M; Terenzi G; Liotti I; Ciotta G; Taddei C; Benucci M; Casprini P; Veneziani F; Fabbri S; Pompetti A; Manfredi M
    J Med Virol; 2020 Sep; 92(9):1671-1675. PubMed ID: 32330291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological tests for SARS-CoV-2 in a health workers population in Nouakchott-Mauritania].
    Salem MLO; Sidiya MAMM; Eibih ABA; Maouloud MM; Ngaide BH; Dedy L; Hamza LM; Yacoub F
    Pan Afr Med J; 2021; 38():55. PubMed ID: 33854684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid serological tests for SARS-CoV-2 IgG/IgM - not worth attention?
    Krygier R; Stępień PM; Zarębska-Michaluk D
    Int J Occup Med Environ Health; 2021 May; 34(2):203-209. PubMed ID: 33734216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2.
    Lapuente D; Maier C; Irrgang P; Hübner J; Peter AS; Hoffmann M; Ensser A; Ziegler K; Winkler TH; Birkholz T; Kremer AE; Steininger P; Korn K; Neipel F; Überla K; Tenbusch M
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):751-759. PubMed ID: 33078221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 was already circulating in Italy, in early December 2019.
    Gragnani L; Monti M; Santini SA; Marri S; Madia F; Lorini S; Petraccia L; Stasi C; Basile U; Luti V; Pagliai F; Saccardi R; Zignego AL
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3342-3349. PubMed ID: 33928622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Rate of Serology and RT-PCR for COVID-19 among Community Residents and Healthcare Workers in Wuhan, China.
    He L; Zeng Y; Zeng C; Zhou Y; Li Y; Xie X; Xu W; Luo W; Hu J; Yi Z; Wang X; Tang S; Xu L; Chen C
    Jpn J Infect Dis; 2021 Jul; 74(4):333-336. PubMed ID: 33390427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of SARS-CoV-2 serological tests with different antigen targets.
    Coste AT; Jaton K; Papadimitriou-Olivgeris M; Greub G; Croxatto A
    J Clin Virol; 2021 Jan; 134():104690. PubMed ID: 33253926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
    Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X
    J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.